Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06594679
Title A Study of Niraparib in Combination with Abemaciclib for Late Line Treatment of Ovarian Cancer (NICHOL TRIAL) (NICHOL)
Acronym NICHOL
Recruitment Not yet recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA


No variant requirements are available.